| 2026-08-05 | Transcript | Q2 FY26 earnings call transcript |
| 2026-08-05 | Deck | Corporate Presentation |
| 2026-08-05 | Press release | RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook |
| 2026-08-05 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-07-26 | Press release | RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules |
| 2026-07-15 | Press release | RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer |
| 2026-07-15 | 8-K | Form 8-K, Item 5.02 |
| 2026-07-06 | Press release | Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs |
| 2026-07-06 | Press release | RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Co · 2026 |
| 2026-07-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-06 | 8-K | Form 8-K, Item 1.01 |
| 2026-06-16 | 8-K | Form 8-K, Item 5.07 |
| 2026-06-08 | Press release | Press release · Q4 2022 · Jun 2026 |
| 2026-05-19 | Press release | RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum |
| 2026-05-06 | Press release | RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook |
| 2026-05-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-06 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-29 | Press release | RxSight, Inc. to Present at the Bank of America Healthcare Conference |
| 2026-04-28 | Proxy | Definitive proxy statement |
| 2026-04-22 | Press release | RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 |
| 2026-04-22 | Press release | RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 |
| 2026-04-08 | Press release | RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 |
| 2026-04-02 | Press release | Press release · Apr 2026 |
| 2026-04-02 | Press release | Press release · Apr 2026 |
| 2026-03-19 | 8-K | Form 8-K/A, Item 5.02 |
| 2026-02-25 | Press release | RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance |
| 2026-02-25 | Press release | RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance |
| 2026-02-25 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-25 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-11 | Press release | RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 |
| 2026-02-11 | Press release | RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 |
| 2026-01-12 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-11 | Press release | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer |
| 2026-01-11 | Press release | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer |
| 2026-01-02 | Press release | Press release · Jan 2026 |
| 2026-01-02 | Press release | Press release · Jan 2026 |
| 2025-12-23 | 8-K | Form 8-K, Item 5.02 |
| 2025-12-22 | 8-K | Form 8-K, Item 5.02 |
| 2025-12-19 | 8-K | Form 8-K, Item 5.02 |